Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis

(2014) Pei-Jian Peng et al.   Drug Design Development and Therapy

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy

(2013) Pei-Jian Peng et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The battle against nasopharyngeal cancer

(2012) Anne W.M. Lee et al.   RADIOTHERAPY AND ONCOLOGY

A phase II study of pemetrexed combined with cisplatin in patients with recurrent or metastatic nanopharyngeal carcinoma

(2011) T.K. Yau et al.   ORAL ONCOLOGY

The prevalence and prevention of nasopharyngeal carcinoma in China

(2011) Su-Mei Cao et al.   Chinese Journal of Cancer

Current treatment options for recurrent nasopharyngeal cancer

(2010) Carlos Suárez et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

S-1: a promising new oral fluoropyrimidine derivative

(2009) Muhammad Wasif Saif et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma

(2008) Yu-Hong Li et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions

(2008) Brigette B. Y. Ma et al.   CANCER SCIENCE

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY